Form 4: Bausch & Lomb Exec Reports Share Transaction

Luc Bonnefoy, President of Surgical at Bausch & Lomb Corp, reported a transaction involving the withholding of common shares for tax obligations.

Summary

• Luc Bonnefoy, President of Surgical at Bausch & Lomb Corp, reported a transaction on May 5, 2026.
• This transaction involved 11,970 common shares withheld to cover tax obligations upon the vesting of restricted share units.
• Following this transaction, Mr. Bonnefoy beneficially owns 88,031 common shares directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it represents a routine tax-related share withholding rather than a discretionary buy or sell transaction by management.

Positives

• The transaction indicates that restricted share units vested, suggesting continued incentive alignment for key management.
• Mr. Bonnefoy retains a significant direct beneficial ownership of 88,031 common shares, demonstrating ongoing commitment to the company.

Negatives

• The withholding of shares for tax purposes represents a reduction in the immediate number of shares available to the reporting person.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions and do not inherently signal strategic shifts, but they do provide transparency into executive compensation and ownership.

Stakeholder Impact

• Shareholders: Increased transparency regarding executive compensation and share ownership.
• Employees: Indirectly, the vesting of RSUs may reflect company performance and employee incentives.
• Management: Luc Bonnefoy's direct beneficial ownership remains substantial after the tax withholding.

Key Dates

Keywords

Bausch & Lomb Corp, BLCO, Form 4, Insider Trading, Stock Transaction, Restricted Share Units, Tax Withholding, Beneficial Ownership